These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Macrophage migration inhibitory factor (MIF) produced by a human T cell hybridoma clone. Hirose S; Ooki S; Higuchi M; Osawa T Microbiol Immunol; 1991; 35(3):235-45. PubMed ID: 1870440 [TBL] [Abstract][Full Text] [Related]
45. Macrophage migration inhibitory factor (MIF) produced by a human T cell hybridoma clone. Oki S; Hirose S; Higuchi M; Osawa T Lymphokine Cytokine Res; 1991 Aug; 10(4):273-80. PubMed ID: 1932371 [TBL] [Abstract][Full Text] [Related]
46. Dissociation of MIF activity and in vitro lymphocyte transformation in the development of experimental allergic thyroiditis in guinea pigs. Hiramine C; Hojo K Tohoku J Exp Med; 1976 Feb; 118(2):137-43. PubMed ID: 790649 [TBL] [Abstract][Full Text] [Related]
47. Affinity purification of macrophage migration inhibitory factor/glycosylation inhibiting factor (MIF/GIF) from bovine brain by using a peptide ligand derived from a novel serpin. Nishibori M; Nakaya N; Mori S; Kawabata M; Tahara A; Saeki K Jpn J Pharmacol; 1996 Jul; 71(3):259-62. PubMed ID: 8854209 [TBL] [Abstract][Full Text] [Related]
48. Production of an antibody against guinea pig MIF. I. Specificity of the anti-MIF antibody. Onozaki K; Haga S; Miura K; Ichikawa M; Hashimoto T Cell Immunol; 1979 Dec; 48(2):258-66. PubMed ID: 389441 [No Abstract] [Full Text] [Related]
49. Effect of the concentration of inducing agent on the output of lymphokines in the guinea pig. Ford WH; Ashworth LA; Inder S Eur J Immunol; 1976 Feb; 6(2):135-8. PubMed ID: 786697 [TBL] [Abstract][Full Text] [Related]
51. Studies on the mechanism of suppression of delayed hypersensitivity by the antischistosomal compund niridazole. Daniels JC; Warren KS; David JR J Immunol; 1975 Nov; 115(5):1414-21. PubMed ID: 51891 [TBL] [Abstract][Full Text] [Related]
52. Production of migration inhibitory factor and lymphotoxin by non-T cells. Bloom BR; Stoner G; Gaffney J; Shevach E; Green I Eur J Immunol; 1975 Mar; 5(3):218-20. PubMed ID: 789088 [TBL] [Abstract][Full Text] [Related]
53. A simple method for the production of migration inhibitory factor by concanavalin A - stimulated lymphocytes. Pick E; Kotkes P J Immunol Methods; 1977; 14(2):141-6. PubMed ID: 320265 [TBL] [Abstract][Full Text] [Related]
55. Purification and characterization of human macrophage migration inhibitory factor: evidence for specific binding to glutathione and formation of subunit structure. Nishihira J; Kuriyama T; Nishino H; Ishibashi T; Sakai M; Nishi S Biochem Mol Biol Int; 1993 Dec; 31(5):841-50. PubMed ID: 8136702 [TBL] [Abstract][Full Text] [Related]
56. Partial purification and characterization of a human lymphokine which induces antileishmanial activity in mouse macrophages. Buchmuller Y; Weiser WY; Remold HG Cell Immunol; 1985 Jan; 90(1):242-50. PubMed ID: 3881189 [TBL] [Abstract][Full Text] [Related]
57. The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Rosengren E; Bucala R; Aman P; Jacobsson L; Odh G; Metz CN; Rorsman H Mol Med; 1996 Jan; 2(1):143-9. PubMed ID: 8900542 [TBL] [Abstract][Full Text] [Related]
58. The biochemistry and in vitro activity of soluble factors of activated lymphocytes. Sorg C Mol Cell Biochem; 1979 Dec; 28(1-3):149-67. PubMed ID: 393992 [TBL] [Abstract][Full Text] [Related]
59. Inhibition of macrophage migration by a factor from ascites fluids of ovarian cancer patients. III. Generation of monoclonal antibody specific for human MIF. Fahlbusch B; Schumann I Biomed Biochim Acta; 1987; 46(5):397-406. PubMed ID: 3311040 [TBL] [Abstract][Full Text] [Related]
60. Fractionation of murine macrophage inhibitory factor into two distinct species. Bout D; Kühner AL; Klimetzek V; Remold HG; David JR Cell Immunol; 1981 Sep; 63(1):198-202. PubMed ID: 7023702 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]